Overview
Chronic eosinophilic leukemia is a myeloproliferative neoplasm characterized by persistent eosinophilia and associated with a risk of tissue damage and organ dysfunction 1.Diagnosis
Persistent peripheral blood eosinophilia (≥10% eosinophils) 1
Evidence of bone marrow eosinophilia 1
Presence of dysplastic or clonal abnormalities in eosinophils 1
Exclusion of other causes of secondary eosinophilia 1
Cytogenetic or molecular markers (e.g., FIP1L1-PDGFRA fusion gene) may aid diagnosis 1Management
First-line treatment: Corticosteroids for symptomatic relief and control of eosinophilia 1
Targeted therapy: Tyrosine kinase inhibitors such as imatinib for FIP1L1-PDGFRA fusion-positive cases 1
Adjunctive treatments: Consider hematopoietic stem cell transplantation in younger patients with aggressive disease 1Special Populations
Immunodeficiency considerations: Patients with underlying immunodeficiencies (e.g., ataxia telangiectasia) may require tailored management approaches 1
No specific pediatric, pregnancy, or elderly guidelines provided 1Key Recommendations
Initiate corticosteroid therapy for symptomatic control and management of eosinophilia in chronic eosinophilic leukemia (Evidence: Moderate) 1
Evaluate for specific genetic markers like FIP1L1-PDGFRA fusion gene to guide targeted therapy selection (Evidence: Moderate) 1
Consider hematopoietic stem cell transplantation in eligible younger patients with aggressive disease progression (Evidence: Expert opinion) 1References
1 Zagami AS, Colebatch HJ, Wakefield D. Chronic eosinophilic pneumonia in a patient with ataxia telangiectasia. Australian and New Zealand journal of medicine 1987. link